Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan

Jul 10, 2021 by in OPHTHALMOLOGY Comments Off on Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan

Purpose To evaluate the effect of select baseline characteristics on geographic atrophy (GA) progression in eyes receiving intravitreal pegcetacoplan or sham. Design Phase 2 multicenter, randomized, single-masked, sham-controlled trial. Methods…

read more

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: the CENTERA Study

Jul 10, 2021 by in OPHTHALMOLOGY Comments Off on Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: the CENTERA Study

Highlights • From baseline to week 76, 65.6% of patients gained ≥15 letters. • In the treat-and-extend phase, 45.0% of patients achieved a mean treatment interval of ≥8 weeks. •…

read more

Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy

Jul 10, 2021 by in OPHTHALMOLOGY Comments Off on Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy

Purpose To evaluate off-label use of netarsudil 0.02% for treatment of corneal edema associated with Fuchs dystrophy. Design Prospective, randomized clinical trial. Methods Twenty-nine subjects with symptomatic Fuchs dystrophy were…

read more

Tube Versus Trabeculectomy IRIS Ⓡ Registry 1-Year Composite Outcome Analysis with Comparisons to the Randomized Controlled Trial

Jul 10, 2021 by in OPHTHALMOLOGY Comments Off on Tube Versus Trabeculectomy IRIS Ⓡ Registry 1-Year Composite Outcome Analysis with Comparisons to the Randomized Controlled Trial

Highlights • TVT IRIS Registry 1-year composite outcome results differ from those of the TVT RCT. • TVT IRIS Registry tube and trabeculectomy failure rates are not significantly different. •…

read more
Get Clinical Tree app for offline access